Article
Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin.
Journal of cutaneous pathology - 1 Feb 2005
Lazar Alexander J F, Calonje Eduardo, Grayson Wayne, Dei Tos Angelo P, Mihm Martin C, Redston Mark, McKee Phillip H
Abstract excerpt
Mutations in beta-catenin are present in benign pilomatrixomas. beta-catenin is a downstream effector in the WNT-signalling pathway, acting as a signal for differentiation and proliferation. Mutations in CTNNB1, the gene encoding beta-catenin, are present in a wide variety of benign and malignant neoplasms. We examined beta-catenin in a series of pilomatrix carcinomas (15 cases) by using immunohistochemistry and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
